Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
---|
02/28/2008 | US20080051407 These compounds lack a 1,4-bridging group as found in the ecteinascidins; and, have at the C-1 position a substituent selected from an amino or hydroxy group, optionally protected or derivatized; anticarcinogenic agents |
02/28/2008 | US20080050795 Mixture Of At Least Two Different Antibodies Specific For Predetermined Antigens And Use Of The Mixture |
02/28/2008 | CA2661401A1 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors |
02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |
02/27/2008 | EP1737837B1 Method for producing optionally substituted methylenedioxybenzene |
02/27/2008 | EP1706366B1 BICYCLO[3.3.1]NONANES AND BICYCLO[3.3.1ßNONENES AND THEIR USE AS FLAVOUR OR FRAGRANCE INGREDIENT |
02/27/2008 | CN101130537A Method for producing ring carbonic acid ester with hydroxyl ion liquid |
02/27/2008 | CN101130528A Process for the preparation of baccatin iii derivatives |
02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
02/21/2008 | WO2008022287A1 Aceonide of hydroxymethylfurfural and glycerin |
02/21/2008 | WO2008019690A1 Substituted acetylenic compounds useful for the treatment of diseases |
02/21/2008 | WO2007062158B1 Adducts of levulinic derivatives with epoxidized fatty acid esters and uses thereof |
02/21/2008 | US20080045713 Tetrahydroisoquinolinedione derivative intermediates for the hemisynthesis of ecteinascidin or other tetrahydroisoquinolinephenol compounds |
02/21/2008 | US20080045705 2-oxoethyl(1R)-4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-[[3,5-dimethyl-4-(phenylmethoxy)phenyl]methyl]-2-[4-(4-morpholinyl)-1-piperidinyl]-1-piperidinecarboxylate; coupling alpha -hydroxy-3,5-dimethyl-4-(phenylmethoxy)-phenylpropionic acid-monosodium salt with 1,3-benzodiazepin compound |
02/21/2008 | US20080045588 Preparation and utility of substituted amphetamines |
02/21/2008 | US20080045546 Tetradydro-Naphthalene And Urea Derivatives |
02/21/2008 | US20080044355 including cystic fibrosis transmembrane conductance regulator ("CFTR"); amido-phenyl derivatives; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema, hereditary hemochromatosis, coagulation-fibrinolysis and lipid processing deficiencies, lysosomal storage disease |
02/21/2008 | DE102004038131B4 Polymerisierbare oder vernetzbare Dotierstoffe, diese enthaltende flüssigkristalline Zusammensetzung und deren Verwendung Polymerizable or crosslinkable dopants containing these liquid crystalline composition and its use |
02/21/2008 | CA2660994A1 Substituted acetylenic compounds useful for the treatment of diseases |
02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
02/20/2008 | EP1888705A1 Reversibly thermochromic compositions |
02/20/2008 | EP1888570A2 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof |
02/20/2008 | EP1888502A2 Catalytic scriabine reaction |
02/20/2008 | EP1055654B1 Process for the preparation of organic compounds with imide catalysts |
02/20/2008 | CN101125847A Method for preparing monochloroethylene carbonate |
02/20/2008 | CN100369910C Method for generating cyclic carbonates using natural reproducible resource |
02/20/2008 | CN100369909C N-[4(R)-(1,3-dioxane)methyl] aniline and its prepn and use |
02/19/2008 | US7332622 Process for preparing optically active nitro compounds and cyano compounds |
02/19/2008 | US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
02/14/2008 | WO2008005954A3 Tryphostin-analogs for the treatment of cell proliferative diseases |
02/14/2008 | US20080038213 1,3-Bis-[3-(4-methoxyphenyl)-2-propenoyloxy]-2-oxopropane; novel alpha-hydroxyketone derivatives as light-protection filters for cosmetic or drug products; used in cosmetic protective coatings; solar radiation; sunscreen agents; aging resistance; wrinkle resistance; food additives; dermatology |
02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
02/13/2008 | EP1299390B1 Pyrimidine compounds and their use in the preparation of a triazolo -pyrimidine carba nucleoside |
02/13/2008 | CN101124213A Sulfonyl amino cyclic derivatives and use thereof as mmp inhibitors |
02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
02/13/2008 | CN101121708A Method for synthesizing oxapium iodide and analogue thereof |
02/13/2008 | CN101121642A Catalytic method used for cyclic carbonates hydrolysis |
02/12/2008 | US7329759 1-Substituted-[1H-indene-6,1'-cyclopropane]-4-one derivatives: solid tumors and multi-drug resistant tumors; may also be targeted to a particular tumor; can either be cytostatic or cytotoxic to the tumor cells |
02/07/2008 | WO2008016677A2 Preparation and utility of deuterated amphetamines |
02/07/2008 | WO2008016596A2 Pseudobase benzo [c] phenanthridines with improved efficacy, stability, and safety |
02/07/2008 | WO2008015231A1 Process for the preparation of alkylene carbonate |
02/07/2008 | US20080033185 Process for the preparation of alkylene carbonate |
02/07/2008 | US20080033171 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
02/07/2008 | US20080033036 Composition and Method for Promoting Hair Growth |
02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
02/07/2008 | US20080032964 Process for the synthesis of azetidinone |
02/07/2008 | CA2663384A1 Process for the preparation of alkylene carbonate |
02/05/2008 | US7326799 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents |
02/05/2008 | US7326731 Muscarinic agonists |
02/05/2008 | US7326710 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent |
02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
02/05/2008 | US7326695 Anti-bacterial agents based upon oxoanion binding |
02/05/2008 | CA2413515C Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them |
01/31/2008 | WO2008011742A1 Method of using organic compounds |
01/31/2008 | US20080027234 Destructible surfactants and uses thereof |
01/31/2008 | US20080027134 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use |
01/31/2008 | CA2659259A1 Modulators of chemokine receptor activity, crystalline forms and process |
01/31/2008 | CA2659253A1 Modulators of chemokine receptor activity, crystalline forms and process |
01/30/2008 | EP1881973A1 Process for producing vinylene carbonate |
01/30/2008 | EP1881972A1 Process for producing vinylene carbonate |
01/30/2008 | EP1881971A1 High-purity vinylene carbonate and a method of purifying vinylene carbonate |
01/30/2008 | EP1881970A1 Method of purifying vinylene carbonate |
01/30/2008 | EP1881969A1 Method of storing and transporting vinylene carbonate |
01/30/2008 | EP1881961A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
01/30/2008 | CN101115748A Acetamide compounds as fungicides |
01/30/2008 | CN101115713A HIV protease inhibitors |
01/29/2008 | CA2326888C Continuous production of 1,3-dioxolan-2-ones |
01/24/2008 | WO2008010455A1 METHOD FOR PRODUCING β-DIARYL ELECTRON-WITHDRAWING GROUP SUBSTITUTED COMPOUND |
01/24/2008 | WO2008009926A2 Safrole replacements |
01/24/2008 | WO2008009138A1 Chlorogenic acid derivatives and their use as anti-fungal agents |
01/24/2008 | WO2007137103A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
01/24/2008 | US20080021228 Method For Producing Optionally Substituted Methylenedioxybenzene |
01/24/2008 | US20080021088 Retinoid Derivatives With Antiangiogenic, Antitumoral And Proapoptotic Activities |
01/24/2008 | DE102006033321A1 Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen Medical use of N-phenylpropenoyl-amino acid derivatives and related compounds |
01/23/2008 | EP1880996A1 Spiroindolinepiperidine derivatives |
01/23/2008 | EP1880720A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same |
01/23/2008 | CN101108843A Method of synthesizing circularity carbonic acid ester containing water or moisture architecture |
01/22/2008 | US7321052 Forming mixture of a glycerol acetal and fatty acid ester by transesterifying triglyceride with an alkanol in presence of acid catalyst (resin acid) and acetalizing glycerol formed with aldehyde, ketone or diether (acetaldehyde or 1,1-di(m)ethoxyethane) in presence of second acid catalyst |
01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
01/22/2008 | CA2374362C Urea derivatives as hiv aspartyl protease inhibitors |
01/17/2008 | WO2008008954A2 Isothiocyanates and glucosinolate compounds and anti-tumor compositios containing same |
01/17/2008 | WO2008006860A2 Preparation of fatty acid esters of glycerol formal and its use as biofuel |
01/17/2008 | WO2007096647A3 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer |
01/17/2008 | US20080015191 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds |
01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
01/16/2008 | EP1689735B1 Method for producing glycerol carbonate methacrylate |
01/16/2008 | EP1687288B1 Substituted aryl cycloalkanol derivatives and methods of their use |
01/16/2008 | EP1622889A4 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives |
01/16/2008 | CN101104578A Optically pure sulfur-containing methyl alkyl alcohol compound |
01/16/2008 | CN100361989C Method for producing (dioxolenon-4-yl)methyl ester derivative |
01/15/2008 | US7319155 Methanesulfonic acid [7-(4-nitrophenyl)-(5H,9H)-6,8-dioxabenzocyclohepten-2-yl]methyl ester; chemical intermediates |
01/10/2008 | WO2008005954A2 Tryphostin-analogs for the treatment of cell proliferative diseases |
01/10/2008 | WO2008004115A1 Process for preparing gabapentin |
01/10/2008 | WO2007131153A3 Methods for the preparation of pyrazole-containing compounds |
01/10/2008 | WO2007062158A3 Adducts of levulinic derivatives with epoxidized fatty acid esters and uses thereof |
01/10/2008 | US20080009630 Photogenerated reagents |
01/10/2008 | US20080009524 Such as 5'-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-2'-methyl-N-(methylsulfonyl)biphenyl-3-carboxamide; cystic fibrosis transmembrane conductance regulator disorders |
01/10/2008 | CA2660769A1 Process for preparing gabapentin |